Skip to content

Insider · CIK 0001940818

Dan Zabrowski

director

Files at ACTU (ACTUATE THERAPEUTICS, INC.). First filing -, latest -.

In brief

Dan Zabrowski files SEC Form 4 as director at ACTU (ACTUATE THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Dan Zabrowski has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 21, 2026ACTU
ACTUATE THERAPEUTICS, INC.
AGrant or award
Stock Optionsderivative
+15,000$0.00$015,000May 22, 2026
May 22, 2025ACTU
ACTUATE THERAPEUTICS, INC.
AGrant or award
Stock Optionsderivative
+15,000$0.00$015,000May 23, 2025
Aug 12, 2024ACTU
ACTUATE THERAPEUTICS, INC.
AGrant or award
Non-Qualified Stock Optionsderivative
+15,000$0.00$015,000Aug 14, 2024

Questions about Dan Zabrowski

Answered from the filings on this page, as of the latest one.

Is Dan Zabrowski buying or selling?

Dan Zabrowski has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Dan Zabrowski's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dan Zabrowski has 0.

Where does Dan Zabrowski file Form 4?

Dan Zabrowski has filed Form 4 at ACTU (ACTUATE THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dan Zabrowski: insider trades and track record | InsiderTell